Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Buy
58
CORBF Quote, Financials, Valuation and Earnings
Last price:
$1.05
Seasonality move
:
-3.66%
Day range:
$1.05 - $1.05
52-week range:
$0.25 - $2.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.66x
P/B ratio:
0.18x
Volume:
--
Avg. volume:
4.6K
1-year change:
-16%
Market cap:
$140.6M
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Global Cord Blood has -- downside to fair value with a price target of -- per share.
CORBF vs. S&P 500
-
Over the past 5 trading days, Global Cord Blood has overperformed the S&P 500 by 7.47% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Global Cord Blood does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Global Cord Blood has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Global Cord Blood reported revenues of --.
Earnings Growth
-
Global Cord Blood earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Global Cord Blood reported earnings per share of --.
Enterprise value:
-906.2M
EV / Invested capital:
--
Price / LTM sales:
0.66x
EV / EBIT:
-9.56x
EV / Revenue:
-4.68x
PEG ratio (5yr expected):
0.41x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
-9.56x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2021-03-31 | 2022-03-31 | |
| Income Statement | ||||||
| Revenue | $175.2M | $171.3M | $193.5M | $46.6M | $46.8M | |
| Gross Profit | $148.1M | $144.9M | $165M | $39.5M | $40.2M | |
| Operating Income | $80.2M | $80.5M | $94.8M | $22.8M | $22.4M | |
| EBITDA | $80.2M | $80.5M | $94.8M | $22.8M | $22.4M | |
| Diluted EPS | $0.56 | $0.62 | $0.64 | $0.16 | $0.14 | |
| Period Ending | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $701.2M | $766.8M | $796.9M | $956.9M | $1.1B | |
| Total Assets | $929.6M | $975.8M | $1B | $1.2B | $1.3B | |
| Current Liabilities | $74.5M | $88.7M | $80.3M | $95.2M | $101.7M | |
| Total Liabilities | $433.5M | $466M | $468.5M | $534.5M | $574M | |
| Total Equity | $496.1M | $509.9M | $546.9M | $666.7M | $768.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2007-03-31 | 2008-03-31 | 2009-03-31 | 2008-03-31 | 2009-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$441.8K | -$598.4K | -$83.6K | -$80.2K | |
| Cash From Investing | -- | $457K | $5.7M | -$161K | -- | |
| Cash From Financing | -- | $18.3K | -$5.2M | -$24.9K | $66.5K | |
| Free Cash Flow | -- | -$441.8K | -$598.4K | -$83.6K | -$80.2K | |
CORBF
Sector
Market Cap
$140.6M
$34.4M
Price % of 52-Week High
52.5%
44.25%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.82%
1-Year Price Total Return
-16%
-39.44%
Beta (5-Year)
-0.640
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.91
200-day SMA
Sell
Level
$1.22
Bollinger Bands (100)
Buy
Level
0.82 - 1.2
Chaikin Money Flow
Buy
Level
22.9M
20-day SMA
Buy
Level
$0.95
Relative Strength Index (RSI14)
Buy
Level
58.36
ADX Line
Buy
Level
15.71
Williams %R
Neutral
Level
-20
50-day SMA
Buy
Level
$0.92
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
16.9M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.
Stock Forecast FAQ
In the current month, CORBF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CORBF average analyst price target in the past 3 months is --.
-
Where Will Global Cord Blood Stock Be In 1 Year?
According to analysts, the consensus estimate is that Global Cord Blood share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Global Cord Blood?
Analysts are divided on their view about Global Cord Blood share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Global Cord Blood is a Sell and believe this share price will rise from its current level to --.
-
What Is Global Cord Blood's Price Target?
The price target for Global Cord Blood over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CORBF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Global Cord Blood is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CORBF?
You can purchase shares of Global Cord Blood via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Global Cord Blood shares.
-
What Is The Global Cord Blood Share Price Today?
Global Cord Blood was last trading at $1.05 per share. This represents the most recent stock quote for Global Cord Blood. Yesterday, Global Cord Blood closed at $1.05 per share.
-
How To Buy Global Cord Blood Stock Online?
In order to purchase Global Cord Blood stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
39
RGC alert for Apr 29
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
76
EXOD alert for Apr 29
Exodus Movement [EXOD] is down 3.2% over the past day.
Sell
48
SBGSY alert for Apr 29
Schneider Electric SE [SBGSY] is down 0.17% over the past day.
